US2013041263A1PendingUtilityA1

Method of detecting a suicide terrorist

Assignee: WU MING-TAPriority: Aug 8, 2011Filed: Aug 8, 2011Published: Feb 14, 2013
Est. expiryAug 8, 2031(~5 yrs left)· nominal 20-yr term from priority
Inventors:Ming-Ta Wu
A61B 5/026A61B 5/165A61B 5/14553
21
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of detecting a suicide terrorist, comprises: (A) selecting a test subject; (B) installing a testing device that can detect real-time variations in cerebral blood flows at a first tested area and second tested area of the subject, wherein the first tested area corresponds to a suicide intent area of a cortex, and the second tested area corresponds to a negative response area of the cortex; (C) using the testing device to detect cortex activity information related to the cerebral blood flow variations of the first tested area within a predetermined time; (D) comparing the cortex activity information with a control group associated with normal individuals to obtain a result; (E) according to the result of step (D), determining whether the subject has suicide intent; (F)asking whether the subject is a terrorist; (G) using the testing device to detect a cortex activity information related to the cerebral blood flow variations of the second tested area within a predetermined time to obtain a result; and (H) according to the result of step (G), determining whether the subject is a terrorist. This method can be advantageously employed at various security check sites, such as airports, train stations, or any other sites susceptible of terrorist attacks.

Claims

exact text as granted — not AI-modified
1 . A method of detecting a suicide terrorist, comprising:
 (A) selecting a test subject;   (B) installing a testing device that can detect real-time variations in cerebral blood flows at a first tested area and second tested area of the subject, wherein the first tested area corresponds to a suicide intent area of a cortex, and the second tested area corresponds to a negative response area of the cortex;   (C) using the testing device to detect cortex activity information related to the cerebral blood flow variations of the first tested area within a predetermined time;   (D) comparing the cortex activity information with a control group associated with normal individuals to obtain a result;   (E) according to the result of step (D), determining whether the subject has suicide intent;   (F) asking whether the subject is a terrorist;   (G) using the testing device to detect cortex activity information related to the cerebral blood flow variations of the second tested area within a predetermined time to obtain a result; and   (H) according to the result of step (G), determining whether the subject is a terrorist.   
     
     
         2 . The method of  claim 1 , wherein the subject is specifically or randomly selected in step (A). 
     
     
         3 . The method of  claim 2 , wherein the subject is selected according to personal background information or an apparent physiologic state of the subject. 
     
     
         4 . The method of  claim 1 , wherein step (A) further comprises asking the subject about a travel purpose. 
     
     
         5 . The method of  claim 1 , wherein the testing device used in step (B) is a near-infrared spectroscopy device for cerebral blood flow detection. 
     
     
         6 . The method of  claim 1 , wherein the first tested area in step (B) has a rectangular shape with a length of 10 cm and a width of 4 cm. 
     
     
         7 . The method of  claim 1 , wherein the predetermined time in steps (C) and (G) is between 1 second and 10 seconds. 
     
     
         8 . The method of  claim 1 , wherein the subject has suicide intent if the result of step (E) shows a significant difference. 
     
     
         9 . The method of  claim 8 , wherein the subject only has suicide intent if the result of step (H) exhibits significant activity. 
     
     
         10 . The method of  claim 8 , wherein the subject is lying and is a suicide terrorist if the result of step (H) does not exhibit significant activity. 
     
     
         11 . The method of  claim 1 , wherein the subject does not have any suicide intent if the result of step (E) shows no significant difference. 
     
     
         12 . The method of  claim 11 , wherein step (H) represents that the subject is a normal individual if the result of step (G) exhibits a significant activity. 
     
     
         13 . The method of  claim 11 , wherein step (H) represents that the subject is lying and is a terrorist without suicide attack intent if the result of step (G) exhibits no significant activity.

Join the waitlist — get patent alerts

Track US2013041263A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.